Pulling SEC filings + quote and writing the call…
PCRX
Pacira BioSciences, Inc.
Next earnings Aug 3, 2026 · consensus $0.66 EPS, $195M rev
Last earnings +1.4% on 2026-04-30
$22.46
▲ +0.58%$22.33▼ -8.26%
over 1Y
L $19.16EODHDH $27.22
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+0.6%
1W-4.4%
1M+0.1%
3M-1.1%
YTD-8.7%
1Y-8.3%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 13 analysts
Buy
Conservative balance sheet (liabilities/equity 0.82x); but thin net margin (1.0%).
The read
Sources: SEC EDGAR (CIK 0001396814, latest 10-Q filed 2026-04-30) · EODHD · as of 6/22/2026, 2:56:33 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.